|
|
|
Financials-Bliss GVS Pharma Limited| Sector: Bulk Drugs and Formulations | | BSE:506197 | NSE:BLISSGVS | Bloomberg:BLIS@IN | Reuters:BLIS.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE416D01022 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
1052.32 |
979.69 |
7.41 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
42.99 |
152.39 |
-71.79 |
| Total Income |
1095.31 |
1132.08 |
-3.25 |
| Total Expenses |
-954.56 |
-896.77 |
6.44 |
| OPBDIT |
2049.87 |
2028.85 |
1.04 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-34.04 |
-896.77 |
-96.20 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-49.14 |
-71.10 |
-30.89 |
| After Tax Profit |
91.61 |
164.21 |
-44.21 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-06(12) |
|
31-Mar-05(12) |
|
31-Mar-04(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
56.24 |
97.22 |
42.71 |
97.74 |
33.05 |
97.85 |
| Operating Income (OI) |
57.85 |
100.00 |
43.70 |
100.01 |
33.77 |
99.99 |
| OPBDIT |
19.44 |
33.61 |
7.95 |
18.19 |
4.72 |
13.97 |
| OPBDT |
19.12 |
33.06 |
7.65 |
17.51 |
4.54 |
13.43 |
| OPBT |
17.88 |
30.91 |
6.91 |
15.81 |
3.93 |
11.64 |
| Non-Operating Income |
0.34 |
0.58 |
0.34 |
0.77 |
0.39 |
1.15 |
| Extraordinary/Prior Period |
-0.39 |
-0.67 |
-0.09 |
-0.21 |
-0.10 |
-0.29 |
| Tax |
6.02 |
10.41 |
2.61 |
5.97 |
1.50 |
4.45 |
| Profit after tax(PAT) |
11.81 |
20.42 |
4.54 |
10.40 |
2.72 |
8.04 |
| Cash Profit |
13.06 |
22.57 |
5.29 |
12.10 |
3.32 |
9.84 |
| Dividend-Equity |
4.15 |
7.17 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
29.78 |
36.86 |
17.57 |
29.41 |
13.22 |
24.09 |
| Net Block |
22.55 |
27.91 |
11.19 |
18.73 |
7.59 |
13.82 |
| Capital WIP |
1.98 |
2.45 |
3.26 |
5.46 |
0.00 |
0.00 |
| Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Inventory |
6.07 |
7.52 |
6.99 |
11.69 |
6.62 |
12.07 |
| Receivables |
21.35 |
26.43 |
12.71 |
21.27 |
9.23 |
16.82 |
| Other Current Assets |
28.84 |
35.70 |
25.60 |
42.85 |
31.45 |
57.29 |
| Balance Sheet Total(BT) |
80.79 |
100.00 |
59.75 |
100.00 |
54.89 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
36.40 |
45.06 |
25.88 |
43.31 |
25.88 |
47.14 |
| Reserves |
7.88 |
9.76 |
10.62 |
17.78 |
6.39 |
11.64 |
| Total Debt |
4.77 |
5.90 |
1.14 |
1.91 |
1.32 |
2.40 |
| Creditors and Acceptances |
1.59 |
1.97 |
2.87 |
4.80 |
1.07 |
1.96 |
| Other current liab/prov. |
30.15 |
37.32 |
19.25 |
32.21 |
20.24 |
36.86 |
| Balance Sheet Total(BT) |
80.79 |
100.00 |
59.75 |
100.00 |
54.89 |
100.00 |
|
| As on |
31-Mar-06 |
31-Mar-05 |
31-Mar-04 |
| OPBIT/Prod.cap.empl.(%) |
38.67 |
20.95 |
12.25 |
| PBIT/Cap. Employed (%) |
38.56 |
21.66 |
13.11 |
| PAT/Networth (%) |
26.67 |
12.45 |
8.42 |
| Tax/PBT (%) |
33.77 |
36.49 |
35.63 |
| Total Debt/Networth (x) |
0.11 |
0.03 |
0.04 |
| Long Term Debt/Networth (x) |
0.00 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
60.60 |
27.83 |
27.41 |
| Current Ratio (x) |
1.77 |
2.05 |
2.22 |
| RM Inventory (days consumption) |
128.40 |
141.02 |
180.62 |
| FG inventory (days cost of sales) |
6.76 |
18.37 |
21.84 |
| Receivables (days gross sales) |
131.05 |
100.64 |
98.85 |
| Creditors (days cost of sales) |
15.11 |
29.26 |
13.50 |
| Op. curr. assets (days OI) |
351.00 |
374.00 |
507.00 |
|
|
Financials